Mark Manson

And we didn't realize how much success we were going to have. And so we have almost 150,000 members. We have millions, tens of millions of data points on people. We're seeing all kinds of trends in the data.

And we didn't realize how much success we were going to have. And so we have almost 150,000 members. We have millions, tens of millions of data points on people. We're seeing all kinds of trends in the data.

And we didn't realize how much success we were going to have. And so we have almost 150,000 members. We have millions, tens of millions of data points on people. We're seeing all kinds of trends in the data.

And we didn't realize how much success we were going to have. And so we have almost 150,000 members. We have millions, tens of millions of data points on people. We're seeing all kinds of trends in the data.

And we didn't realize how much success we were going to have. And so we have almost 150,000 members. We have millions, tens of millions of data points on people. We're seeing all kinds of trends in the data.

And we didn't realize how much success we were going to have. And so we have almost 150,000 members. We have millions, tens of millions of data points on people. We're seeing all kinds of trends in the data.

And we didn't realize how much success we were going to have. And so we have almost 150,000 members. We have millions, tens of millions of data points on people. We're seeing all kinds of trends in the data.

And we didn't realize how much success we were going to have. And so we have almost 150,000 members. We have millions, tens of millions of data points on people. We're seeing all kinds of trends in the data.

And we didn't realize how much success we were going to have. And so we have almost 150,000 members. We have millions, tens of millions of data points on people. We're seeing all kinds of trends in the data.

And we didn't realize how much success we were going to have. And so we have almost 150,000 members. We have millions, tens of millions of data points on people. We're seeing all kinds of trends in the data.

We see that people actually, when they get their first test, and now we've been going two years, we can see that when they follow up and do the follow-up testing, that their biomarkers get better. Their blood sugar gets better. Their cholesterol gets better. Their inflammation gets better. Their vitamin D gets better. Whatever is off.

We see that people actually, when they get their first test, and now we've been going two years, we can see that when they follow up and do the follow-up testing, that their biomarkers get better. Their blood sugar gets better. Their cholesterol gets better. Their inflammation gets better. Their vitamin D gets better. Whatever is off.

We see that people actually, when they get their first test, and now we've been going two years, we can see that when they follow up and do the follow-up testing, that their biomarkers get better. Their blood sugar gets better. Their cholesterol gets better. Their inflammation gets better. Their vitamin D gets better. Whatever is off.

We see that people actually, when they get their first test, and now we've been going two years, we can see that when they follow up and do the follow-up testing, that their biomarkers get better. Their blood sugar gets better. Their cholesterol gets better. Their inflammation gets better. Their vitamin D gets better. Whatever is off.

We see that people actually, when they get their first test, and now we've been going two years, we can see that when they follow up and do the follow-up testing, that their biomarkers get better. Their blood sugar gets better. Their cholesterol gets better. Their inflammation gets better. Their vitamin D gets better. Whatever is off.

We see that people actually, when they get their first test, and now we've been going two years, we can see that when they follow up and do the follow-up testing, that their biomarkers get better. Their blood sugar gets better. Their cholesterol gets better. Their inflammation gets better. Their vitamin D gets better. Whatever is off.

We see that people actually, when they get their first test, and now we've been going two years, we can see that when they follow up and do the follow-up testing, that their biomarkers get better. Their blood sugar gets better. Their cholesterol gets better. Their inflammation gets better. Their vitamin D gets better. Whatever is off.

We see that people actually, when they get their first test, and now we've been going two years, we can see that when they follow up and do the follow-up testing, that their biomarkers get better. Their blood sugar gets better. Their cholesterol gets better. Their inflammation gets better. Their vitamin D gets better. Whatever is off.

We see that people actually, when they get their first test, and now we've been going two years, we can see that when they follow up and do the follow-up testing, that their biomarkers get better. Their blood sugar gets better. Their cholesterol gets better. Their inflammation gets better. Their vitamin D gets better. Whatever is off.

We see that people actually, when they get their first test, and now we've been going two years, we can see that when they follow up and do the follow-up testing, that their biomarkers get better. Their blood sugar gets better. Their cholesterol gets better. Their inflammation gets better. Their vitamin D gets better. Whatever is off.